Wang J - Search Results

1

Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.

Huang R, Wang J, Yan X, Xia J, Wu C. Huang R, et al. Among authors: wang j. Aliment Pharmacol Ther. 2019 Sep;50(5):618-619. doi: 10.1111/apt.15423. Aliment Pharmacol Ther. 2019. PMID: 31414546 No abstract available.

2

Characteristics of hepatitis B core antibody level in the natural history of chronic hepatitis B.

Wang J, Yan X, Chen Y, Liu Y, Wang L, Jia B, Wang G, Xiong Y, Song P, Wu W, Xia J, Lu S, Zhang Z, Huang R, Wu C. Wang J, et al. Among authors: wang g, wang l. Discov Med. 2018 Oct;26(143):119-125. Discov Med. 2018. PMID: 30586535 Free article. Clinical Trial.

3

Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients.

Huang R, Yao R, Wu W, Wang J, Wu C. Huang R, et al. Among authors: wang j. Aliment Pharmacol Ther. 2019 Apr;49(8):1105-1106. doi: 10.1111/apt.15150. Aliment Pharmacol Ther. 2019. PMID: 30920033 No abstract available.

4

Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes in non-alcoholic fatty liver disease.

Huang R, Wu W, Wang J, Zhang Z, Wu C. Huang R, et al. Among authors: wang j. Aliment Pharmacol Ther. 2019 Aug;50(3):338. doi: 10.1111/apt.15362. Aliment Pharmacol Ther. 2019. PMID: 31313357 No abstract available.

5

Letter: clinical outcomes after long-term entecavir or tenofovir treatment in patients with hepatitis D and advanced fibrosis.

Huang R, Wang J, Wu W, Yan X, Wu C. Huang R, et al. Among authors: wang j. Aliment Pharmacol Ther. 2019 Aug;50(4):471. doi: 10.1111/apt.15367. Aliment Pharmacol Ther. 2019. PMID: 31359471 No abstract available.

6

Letter to the Editor: Impact of Nonalcoholic Steatohepatitis on Liver-Related Outcomes in Chronic Hepatitis B.

Huang R, Wang J, Zhang Z, Yan X, Wu C. Huang R, et al. Among authors: wang j. Hepatology. 2020 Feb;71(2):767. doi: 10.1002/hep.30981. Epub 2020 Jan 24. Hepatology. 2020. PMID: 31587343 No abstract available.

7

HBeAg Negativity Is Associated With More Advanced Liver Fibrosis in Patients With Chronic Hepatitis B: A Propensity Score-Matching Analysis.

Wang J, Wu W, Yan X, Wei J, Yao K, Yang Y, Xiong Y, Xia J, Liu Y, Chen Y, Jia B, Zhang Z, Ding W, Huang R, Wu C. Wang J, et al. J Clin Gastroenterol. 2020 Oct;54(9):826-831. doi: 10.1097/MCG.0000000000001291. J Clin Gastroenterol. 2020. PMID: 31789771

8

Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.

Huang R, Wang J, Wu W, Yan X, Wu C. Huang R, et al. Among authors: wang j. Hepatology. 2020 Jun;71(6):2173-2174. doi: 10.1002/hep.31080. Hepatology. 2020. PMID: 31858599 No abstract available.

9

The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.

Wang J, Chen Z, Yan X, Yang Y, Liu Y, Chen Y, Jia B, Xia J, Xiong Y, Zhang Z, Ding W, Huang R, Wu C. Wang J, et al. Discov Med. 2019 Sep;28(153):149-158. Discov Med. 2019. PMID: 31926586 Free article.

10

Reply to the letter by Beyan et al "Plateletcrit may not be an index for predicting of liver fibrosis in patients with chronic hepatitis B".

Huang R, Wang J, Xia J, Wu C. Huang R, et al. Among authors: wang j. J Viral Hepat. 2020 Jul;27(7):758. doi: 10.1111/jvh.13288. Epub 2020 Apr 15. J Viral Hepat. 2020. PMID: 32196845 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218,539 results

Search Page

Filters